Literature DB >> 19195674

Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus.

Kazuya Shirato1, Fumihiro Taguchi.   

Abstract

Respiratory syncytial virus (RSV), a major causative agent of respiratory tract infections, influences allergic diseases. Mast cells, important effector cells in allergic disease, also express chemokine (C-X(3)-C motif) receptor 1 (CX(3)CR1). The RSV attachment glycoprotein (G protein) is structurally similar to CX(3)C ligand 1 (CX(3)CL1), the CX(3)CR1 ligand, suggesting that RSV directly interacts with and affects mast cell function, including degranulation. In this paper, the effect of RSV infection on mast cell function was studied using the human mast cell line (HMC-1). The results showed that RSV infection and replication was inefficient in HMC-1 cells than in human epithelial A549 cells. Additionally, HMC-1 degranulation occurred only in coculture with RSV-infected A549 cells, with up-regulation of TNFalpha secretion. However, direct RSV inoculation and incubation with RSV-infected A549 cell culture medium failed to induce HMC-1 degranulation, suggesting that virus-infected cells are critical for degranulation during RSV infection; however, degranulation does not occur by direct RSV infection into mast cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19195674     DOI: 10.1016/j.virol.2009.01.011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Mast cell-induced lung injury in mice infected with H5N1 influenza virus.

Authors:  Yanxin Hu; Yi Jin; Deping Han; Guozhong Zhang; Shanping Cao; Jingjing Xie; Jia Xue; Yi Li; Di Meng; Xiaoxu Fan; Lun-Quan Sun; Ming Wang
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

2.  Limited replication of influenza A virus in human mast cells.

Authors:  Candy W Marcet; Chris D St Laurent; Tae Chul Moon; Nav Singh; A Dean Befus
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

3.  Microwave-irradiation-assisted hybrid chemical approach for titanium dioxide nanoparticle synthesis: microbial and cytotoxicological evaluation.

Authors:  Shivendu Ranjan; Nandita Dasgupta; Bhavapriya Rajendran; Ganesh S Avadhani; Chidambaram Ramalingam; Ashutosh Kumar
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-15       Impact factor: 4.223

Review 4.  Mast cell-orchestrated immunity to pathogens.

Authors:  Soman N Abraham; Ashley L St John
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 5.  Mast Cells in the Skin: Defenders of Integrity or Offenders in Inflammation?

Authors:  Martin Voss; Johanna Kotrba; Evelyn Gaffal; Konstantinos Katsoulis-Dimitriou; Anne Dudeck
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

6.  Role and relevance of mast cells in fungal infections.

Authors:  R Saluja; M Metz; Marcus Maurer
Journal:  Front Immunol       Date:  2012-06-13       Impact factor: 7.561

7.  Influenza A Viruses Replicate Productively in Mouse Mastocytoma Cells (P815) and Trigger Pro-inflammatory Cytokine and Chemokine Production through TLR3 Signaling Pathway.

Authors:  Di Meng; Caiyun Huo; Ming Wang; Jin Xiao; Bo Liu; Tangting Wei; Hong Dong; Guozhong Zhang; Yanxin Hu; Lunquan Sun
Journal:  Front Microbiol       Date:  2017-01-12       Impact factor: 5.640

Review 8.  Mast Cells in Cardiac Fibrosis: New Insights Suggest Opportunities for Intervention.

Authors:  Stephanie A Legere; Ian D Haidl; Jean-François Légaré; Jean S Marshall
Journal:  Front Immunol       Date:  2019-03-28       Impact factor: 7.561

Review 9.  Mast Cell Responses to Viruses and Pathogen Products.

Authors:  Jean S Marshall; Liliana Portales-Cervantes; Edwin Leong
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

10.  Increased replication of respiratory syncytial virus in the presence of cytokeratin 8 and 18.

Authors:  Kazuya Shirato; Makoto Ujike; Miyuki Kawase; Shutoku Matsuyama
Journal:  J Med Virol       Date:  2012-02       Impact factor: 2.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.